Dunn RJ
On the Deep venous thrombosis page under Management, the doses of heparin (5000Units bd) and enoxaparin (40mg/day) previously quoted on this page are for prophylaxis, and not treatment of DVT. The correct dose of enoxaparin is 1mg/kg bd (reduced in renal failure) and the correct dose of IV heparin is a loading dose of 75 – … Read more
The Management of PE , Heparin and Deep venous thrombosis pages have been updated with additional information about the dosing of enoxaparin in extremes of body weight and renal impairment.
A small segment on disposition of patients following paracetamol ingestion has been added to the Paracetamol page.
The Reversal of anti-coagulation page has been extensively revised to incorporate the latest Australasian Society of Thrombosis and Haemostasis guidelines.
A new chapter has been created in the Haematological disorders section called Anti-coagulation and anti-thrombotic therapy. This chapter contains information about all types of anti-coagulant agents and vena caval filters and should make it easier to find information about these treatments .
Details of the HAS BLED score for predicting haemorrhage in patients on warfarin therapy has been added to the Warfarin page.
Details about the CHA2dS2VASc score for predicting the risk of stroke in AF has been added to the Stroke prevention in atrial fibrillation/flutter page and other updates to this section have also occurred.
The information about Atrial Flutter has moved from the Other arrhythmias page to the newly named Assessment of atrial fibrillation / flutter page to reflect the similarity of these conditions.
The search function index files have just been updated. This needs to be done every so often to make sure the search engine can find new content or content that may have been moved. This takes a bit of time to do as there are nearly 2000 pages to index – the reason we don’t … Read more
Additional content regarding the types of dysphasias has been added to the Assessment of speech page.
The final results of the preferred anti-emetic agent poll are in with ondansetron (69%) clearly more popular than metoclopramide (31%). Surprisingly, no-one voted for prochlorperazine or tropisitron. The results are encouraging as ondansetron apppears to have a greater effect on nausea and vomiting from non migranous causes than metoclopramide, with fewer adverse effects. Metoclopramide is … Read more
A series of images demonstrating different types of visual field defects have been added to the Assessment of vision page along with some useful links to relevant pages in other parts of the manual and additional information about occipital cortical blindness.
A small segment on normal visual development in children has been added to the Assessment of vision page.
Additional descriptions of some types of movement disorders have been added to the Other movement disorders page.
A variety of LRs for features of Parkinson’s disease have been added to the Parkinson’s disease page.